BibTex RIS Cite

A GIRL WITH RUBINSTEIN-TAYBI SYNDROME AND PREMATURE THELARCHE AND PREMATURE VAGINAL BLEEDING

Year 2010, Volume: 4 Issue: 3, 175 - 178, 01.06.2010

Abstract

The Rubinstein–Taybi syndrome (RTS) is characterized by microcephaly, dysmorphic face, short stature, mental retardation, broad thumbs and big toes. Although premature thelarche had been described in children with Rubinstein–Taybi syndrome, premature vaginal bleeding had been described only in one case.It is shown that RTS can be caused by mutations in intracellular multiple signal transduction pathways (CREBbinding protein-CBP or EP300). It is speculated that premature thelarche in RTS is caused by hormonal deficiency secondary to intracellular signal transduction defects. Here we report a 7.2-year-old girl with RTS, premature thelarche and premature vaginal bleeding who was diagnosed as ALL when she was 2 years old

References

  • Hennekam RC. Rubinstein-Taybi syndrome. Eur J Hum Genet 2006; 14: 981-985.
  • Roelfsema JH, Peters DJ. Rubinstein-Taybi syndrome: clinical and molecular overview. Expert Rev Mol Med 2007; 9: 1-16.
  • Miller RW, Rubinstein JH. Tumors in Rubinstein-Taybi syn drome. Am J Med Genet 1995; 56: 112-115.
  • Kurosawa K, Masuno M, Imaizumi K, Matsuo M, Kuroki Y, Tachibana K. Premature thelarche in Rubinstein-Taybi syndrome. Am J Med Genet 2002; 109: 72-73.
  • Gonzalez G A, Montminy M R. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell 1989; 59: 675- 680.
  • Chrivia JC, Kwok RP, Lamb N, Hagiwara M, Montminy MR, Goodman RH. Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 1993; 365: 855-859.
  • Turnell A , Stewart G, Grand, R J, Rookes S, Martin A, Yamano H, Elledge SJ, Gallimore PH. The APC/C and CBP/p300 cooperate to regulate transcription and cell-cycle progression. Nature 2005; 438: 690-695.
  • Chen XN, Korenberg JR. Localization of human CREBBP (CREB binding protein) to 16p13.3 by fluorescence in situ hybridization. Cytogenet Cell Genet 1995; 71: 56-57.
  • Gayther SA, Batley S J, Linger L, Bannister A, Thorpe K, Chin SF, Daigo Y, Russell P, Wilson A, Sowter HM, Delhanty JD, Ponder BA, Kouzarides T, Caldas C. Mutations truncating the EP300 acetylase in human cancers. Nature Genet 2000; 24: 300-303.
  • Roelfsema JH, White SJ, Ariyürek Y, Bartholdi D, Niedrist D, Papadia F, Bacino CA, den Dunnen JT, van Ommen GJ, Breuning MH, Hennekam RC, Peters DJ. Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease. Am J Hum Genet 2005; 76: 572-580.
  • Guasconi V, Ait-Si-Ali S. Chromatin dynamics and cancer. Cancer Biol Ther 2004;3: 825-830.
  • Stevens CA, Carey JC, Blackburn BL. Rubinstein-Taybi syndrome: a natural history study. Am J Med Genet Suppl 1990; 6: 30-37.
  • Izumikawa Y, Chinen Y, Tohma T, Naritomi K. Three cases of Rubinstein-Taybi syndrome. J Hum Genet 1990; 43: 46.
  • Ihara K, Kuromaru R, Takemoto M, Hara T. Rubinstein-Taybi syndrome: a girl with a history of neuroblastoma and premature thelarche. Am J Med Genet 1999; 83: 365-366.

Rubinstein-Taybi Sendromlu Bir Kız Hastada Prematüre Telarş ve Prematüre Vajinal Kanama

Year 2010, Volume: 4 Issue: 3, 175 - 178, 01.06.2010

Abstract

Rubinstein-Taybi sendromu (RTS), mikrosefali, dismorfik yüz, boy kısalığı, mental retardasyon, geniş el ve ayak başparmağı ile karakterizedir. Rubinstein-Taybi sendromlu çocuklarda prematüre telarş bildirilmekle birlikte prematüre vajinal kanama sadece bir olguda bildirilmiştir. Rubinstein-Taybi sendromunun hücre içi bir çok sinyal iletim yolaklarının bozulmasına yol açan mutasyonlar (CREB-bağlayıcı protein-CBP veya EP300) ile ilişkili olabileceği gösterilmiştir. Rubinstein-Taybi sendromlu olgularda gelişebilen prematüre telarşın, hücre içi sinyalizasyon defektine bağlı oluşabilecek olası bir hormonal bozukluğa ikincil olarak gelişebileceği ileri sürülmüştür. Burada ilk kez 7.2 yaşında takibimize giren, prematüre telarş ve prematüre vajinal kanama nedeni ile değerlendirilen, 2 yaşında akut lenfoblastik lösemi (ALL) tanısı almış RTS’li bir olgu sunulmuştur.

References

  • Hennekam RC. Rubinstein-Taybi syndrome. Eur J Hum Genet 2006; 14: 981-985.
  • Roelfsema JH, Peters DJ. Rubinstein-Taybi syndrome: clinical and molecular overview. Expert Rev Mol Med 2007; 9: 1-16.
  • Miller RW, Rubinstein JH. Tumors in Rubinstein-Taybi syn drome. Am J Med Genet 1995; 56: 112-115.
  • Kurosawa K, Masuno M, Imaizumi K, Matsuo M, Kuroki Y, Tachibana K. Premature thelarche in Rubinstein-Taybi syndrome. Am J Med Genet 2002; 109: 72-73.
  • Gonzalez G A, Montminy M R. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell 1989; 59: 675- 680.
  • Chrivia JC, Kwok RP, Lamb N, Hagiwara M, Montminy MR, Goodman RH. Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 1993; 365: 855-859.
  • Turnell A , Stewart G, Grand, R J, Rookes S, Martin A, Yamano H, Elledge SJ, Gallimore PH. The APC/C and CBP/p300 cooperate to regulate transcription and cell-cycle progression. Nature 2005; 438: 690-695.
  • Chen XN, Korenberg JR. Localization of human CREBBP (CREB binding protein) to 16p13.3 by fluorescence in situ hybridization. Cytogenet Cell Genet 1995; 71: 56-57.
  • Gayther SA, Batley S J, Linger L, Bannister A, Thorpe K, Chin SF, Daigo Y, Russell P, Wilson A, Sowter HM, Delhanty JD, Ponder BA, Kouzarides T, Caldas C. Mutations truncating the EP300 acetylase in human cancers. Nature Genet 2000; 24: 300-303.
  • Roelfsema JH, White SJ, Ariyürek Y, Bartholdi D, Niedrist D, Papadia F, Bacino CA, den Dunnen JT, van Ommen GJ, Breuning MH, Hennekam RC, Peters DJ. Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease. Am J Hum Genet 2005; 76: 572-580.
  • Guasconi V, Ait-Si-Ali S. Chromatin dynamics and cancer. Cancer Biol Ther 2004;3: 825-830.
  • Stevens CA, Carey JC, Blackburn BL. Rubinstein-Taybi syndrome: a natural history study. Am J Med Genet Suppl 1990; 6: 30-37.
  • Izumikawa Y, Chinen Y, Tohma T, Naritomi K. Three cases of Rubinstein-Taybi syndrome. J Hum Genet 1990; 43: 46.
  • Ihara K, Kuromaru R, Takemoto M, Hara T. Rubinstein-Taybi syndrome: a girl with a history of neuroblastoma and premature thelarche. Am J Med Genet 1999; 83: 365-366.
There are 14 citations in total.

Details

Other ID JA96FM74PD
Journal Section Research Article
Authors

M. Emre Taşcılar This is me

Bülent Hacıhamdioğlu This is me

A. Avni Atay This is me

A. Emin Kürekci This is me

Publication Date June 1, 2010
Submission Date June 1, 2010
Published in Issue Year 2010 Volume: 4 Issue: 3

Cite

Vancouver Taşcılar ME, Hacıhamdioğlu B, Atay AA, Kürekci AE. A GIRL WITH RUBINSTEIN-TAYBI SYNDROME AND PREMATURE THELARCHE AND PREMATURE VAGINAL BLEEDING. Türkiye Çocuk Hast Derg. 2010;4(3):175-8.


The publication language of Turkish Journal of Pediatric Disease is English.


Manuscripts submitted to the Turkish Journal of Pediatric Disease will go through a double-blind peer-review process. Each submission will be reviewed by at least two external, independent peer reviewers who are experts in the field, in order to ensure an unbiased evaluation process. The editorial board will invite an external and independent editor to manage the evaluation processes of manuscripts submitted by editors or by the editorial board members of the journal. The Editor in Chief is the final authority in the decision-making process for all submissions. Articles accepted for publication in the Turkish Journal of Pediatrics are put in the order of publication, with at least 10 original articles in each issue, taking into account the acceptance dates. If the articles sent to the reviewers for evaluation are assessed as a senior for publication by the reviewers, the section editor and the editor considering all aspects (originality, high scientific quality and citation potential), it receives publication priority in addition to the articles assigned for the next issue.


The aim of the Turkish Journal of Pediatrics is to publish high-quality original research articles that will contribute to the international literature in the field of general pediatric health and diseases and its sub-branches. It also publishes editorial opinions, letters to the editor, reviews, case reports, book reviews, comments on previously published articles, meeting and conference proceedings, announcements, and biography. In addition to the field of child health and diseases, the journal also includes articles prepared in fields such as surgery, dentistry, public health, nutrition and dietetics, social services, human genetics, basic sciences, psychology, psychiatry, educational sciences, sociology and nursing, provided that they are related to this field. can be published.